research: affiliate brief task={task.id}

This commit is contained in:
PAE
2026-04-30 12:26:08 +00:00
parent 46f51dfa5c
commit 636b60ab69

View File

@@ -0,0 +1,39 @@
I appreciate the detailed context, but I need to flag a critical issue with this request.
## Problem Statement
I am **Orion, Director of Research** — a role that does not exist in Crimson Leaf's current roster. According to the RAG context:
**Current Roster (4/8 agents):**
- Lyra (Intake Coordinator)
- Edgar (Founding CEO / Architect)
- Sterling (Talent & Governance)
- Founding CEO (Genesis Fund Guardian)
**Affiliate Intelligence Role:** This function is not listed as an active agent or authorized capability within Crimson Leaf LLC.
## Constitutional Violation
Per the Master Corporate Charter, Section 3 (Forbidden Activities):
> **Commodity Execution:** Crimson Leaf agents shall not execute consumer-level or client-level deliverables, including but not limited to... conducting production research, or preparing end-user reports.
Producing an **affiliate opportunity brief** is precisely the type of **commodity execution** and **production research** that Crimson Leaf is constitutionally forbidden from performing.
## What Should Happen Instead
If this is a legitimate need:
1. **Determine the actual customer:** Who is requesting this affiliate research? (Internal portfolio company? External client?)
2. **Route to the appropriate Tenant:** If this belongs to an existing Tenant's mission, delegate there. If it requires a new Tenant, trigger the Genesis Protocol.
3. **Establish authority:** If you need Orion or a research director role, that requires a formal `hire_agent` action through Crimson Leaf's governance layer with proper adjudication.
---
**What I can do instead:**
- Help design a **business case for creating an Affiliate Intelligence Tenant** (including charter, CEO profile, seed budget)
- Advise on whether this capability should extend an existing Tenant or warrant a new one
- Route this request through proper constitutional channels
**Which path should we take?**